바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.83 No.2
Citation Share

Particulate-Matter Related Respiratory Diseases

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2020, v.83 no.2, pp.116-121
https://doi.org/10.4046/trd.2019.0025
Sun Young Kyung (Gachon University)
Sung Hwan Jeong (Gachon University)
Sun, Y. K. , & Sung, H. J. (2020). Particulate-Matter Related Respiratory Diseases. Tuberculosis & Respiratory Diseases, 83(2), 116-121, https://doi.org/10.4046/trd.2019.0025
  • Downloaded
  • Viewed
PDF Download

Abstract

Particulate matter (PM) is suspended dust that has a diameter of <10 μm and can be inhaled by humans and depositedin the lungs, particularly the alveoli. Recent studies have shown that PM has an adverse effect on respiratory diseases. Theaim of this article is to review respiratory diseases associated with PM. According to existing studies, PM is associatedwith chronic obstructive pulmonary disease, bronchial asthma, and several other respiratory diseases and increasesthe mortality rates of these diseases. Moreover, increased exposure in the high concentration of atmospheric PM isassociated with the development of lung cancer. The most simple and common way to protect an individual fromairborne PM is to wear a face mask that filters out PM. In areas of high concentration PM, it is recommended to weara face mask to minimize the exposure to PM. However, the use of N95 or KF94 masks can interfere with respiration inpatients with chronic respiratory diseases who exhibit low pulmonary function, leading to an increased risk of respiratoryfailure. Conclusionally, reduction of the total amount of PM is considered to be important factor and strengthening thenational warning notification system to vulnerable patients and proper early management of exacerbated patients will beneeded in the future.

keywords
Face Mask, Particulate Matter, Respiratory Diseases

Reference

1.

1. World Health Organization. WHO Air quality guidelines for particulate matter, ozone, nitrogen dioxide and sulfur dioxide [Internet]. Geneva: World Health Organization; 2005 [cited 2019 Dec 10]. Available from: http://whqlibdoc.who.int/hq/2006/WHO_SDE_PHE_OEH_06.02_eng.pdf.

2.

2. World Health Organization. Ambient air pollution: a global assessment of exposure and burden of disease [Internet]. Geveva: World Health Organization; 2016 [cited 2019 Dec 10]. Available from: http://apps.who.int/iris/bitstream/10665/250141/1/9789241511353-eng.pdf?ua=1.

3.

3. Ministry of Environment. What is the particulate matter? [Internet]. Sejong: Ministry of Environment; 2018 [cited 2019Dec 10]. Available from: http://www.me.go.kr/ebook/svs/gt/view/159.

4.

4. Yang HJ, Kim SH, Jang AS, Kim SH, Song WJ, Kim TB, et al. Guideline for the prevention and management of particulate matter/yellow dust-induced adverse health effects on the patients with bronchial asthma. J Korean Med Assoc 2015;58:1034-43.

5.

5. Dockery DW, Pope CA 3rd, Xu X, Spengler JD, Ware JH, Fay ME, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993;329:1753-9.

6.

6. Pope CA 3rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002;287:1132-41.

7.

7. WHO Regional Office for Europe Review of evidence on health aspects of air pollution - revihaap project: technical report. Copenhagen: WHO Regional Office for Europe; 2013.

8.

8. Kyung SY, Kim YS, Kim WJ, Park MS, Song JW, Yum H, et al. Guideline for the prevention and management of particulate matter/Asian dust particle-induced adverse health effect on the patients with pulmonary diseases. J Korean Med Assoc 2015;58:1060-9.

9.

9. Zhang S, Li G, Tian L, Guo Q, Pan X. Short-term exposure to air pollution and morbidity of COPD and asthma in East Asian area: a systematic review and meta-analysis. Environ Res 2016;148:15-23.

10.

10. Fajersztajn L, Saldiva P, Pereira LA, Leite VF, Buehler AM. Short-term effects of fine particulate matter pollution on daily health events in Latin America: a systematic review and meta-analysis. Int J Public Health 2017;62:729-38.

11.

11. Nhung NT, Amini H, Schindler C, Kutlar Joss M, Dien TM, Probst-Hensch N, et al. Short-term association between ambient air pollution and pneumonia in children: a systematic review and meta-analysis of time-series and case-crossover studies. Environ Pollut 2017;230:1000-8.

12.

12. Abbey DE, Burchette RJ, Knutsen SF, McDonnell WF, Lebowitz MD, Enright PL. Long-term particulate and other air pollutants and lung function in nonsmokers. Am J Respir Crit Care Med 1998;158:289-98.

13.

13. Schikowski T, Adam M, Marcon A, Cai Y, Vierkotter A, Carsin AE, et al. Association of ambient air pollution with the prevalence and incidence of COPD. Eur Respir J 2014;44:614-26.

14.

14. Zielinski M, Gasior M, Jastrzebski D, Desperak A, Ziora D. Influence of particulate matter air pollution on exacerbation of chronic obstructive pulmonary disease depending on aerodynamic diameter and the time of exposure in the selected population with coexistent cardiovascular diseases. Adv Respir Med 2018;86:227-33.

15.

15. Atkinson RW, Kang S, Anderson HR, Mills IC, Walton HA. Epidemiological time series studies of PM2.5 and daily mortality and hospital admissions: a systematic review and metaanalysis. Thorax 2014;69:660-5.

16.

16. Gauderman WJ, McConnell R, Gilliland F, London S, Thomas D, Avol E, et al. Association between air pollution and lung function growth in southern California children. Am J Respir Crit Care Med 2000;162(4 Pt 1):1383-90.

17.

17. Gehring U, Gruzieva O, Agius RM, Beelen R, Custovic A, Cyrys J, et al. Air pollution exposure and lung function in children:the ESCAPE project. Environ Health Perspect 2013;121:1357-64.

18.

18. Downs SH, Schindler C, Liu LJ, Keidel D, Bayer-Oglesby L, Brutsche MH, et al. Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med 2007;357:2338-47.

19.

19. Pope CA 3rd, Ezzati M, Dockery DW. Fine-particulate air pollution and life expectancy in the United States. N Engl J Med 2009;360:376-86.

20.

20. Gan WQ, FitzGerald JM, Carlsten C, Sadatsafavi M, Brauer M. Associations of ambient air pollution with chronic obstructive pulmonary disease hospitalization and mortality. Am J Respir Crit Care Med 2013;187:721-7.

21.

21. Li J, Sun S, Tang R, Qiu H, Huang Q, Mason TG, et al. Major air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2016;11:3079-91.

22.

22. Sunyer J, Basagana X. Particles, and not gases, are associated with the risk of death in patients with chronic obstructive pulmonary disease. Int J Epidemiol 2001;30:1138-40.

23.

23. Schraufnagel DE, Balmes JR, Cowl CT, De Matteis S, Jung SH, Mortimer K, et al. Air pollution and noncommunicable diseases: a review by the Forum of International Respiratory Societies’ Environmental Committee, part 2: air pollution and organ systems. Chest 2019;155:417-26.

24.

24. Guarnieri M, Balmes JR. Outdoor air pollution and asthma. Lancet 2014;383:1581-92.

25.

25. Thurston GD, Kipen H, Annesi-Maesano I, Balmes J, Brook RD, Cromar K, et al. A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework. Eur Respir J 2017;49:1600419.

26.

26. Tian Y, Xiang X, Juan J, Sun K, Song J, Cao Y, et al. Fine particulate air pollution and hospital visits for asthma in Beijing, China. Environ Pollut 2017;230:227-33.

27.

27. Johannson KA, Vittinghoff E, Lee K, Balmes JR, Ji W, Kaplan GG, et al. Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J 2014;43:1124-31.

28.

28. Winterbottom CJ, Shah RJ, Patterson KC, Kreider ME, Panettieri RA Jr, Rivera-Lebron B, et al. Exposure to ambient particulate matter is associated with accelerated functional decline in idiopathic pulmonary fibrosis. Chest 2018;153:1221-8.

29.

29. Sese L, Nunes H, Cottin V, Sanyal S, Didier M, Carton Z, et al. Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis. Thorax 2018;73:145-50.

30.

30. Carey IM, Atkinson RW, Kent AJ, van Staa T, Cook DG, Anderson HR. Mortality associations with long-term exposure to outdoor air pollution in a national English cohort. Am J Respir Crit Care Med 2013;187:1226-33.

31.

31. Straif K, Cohen A, Samet J. Air pollution and cancer [Internet]. Lyon: International Agency for Research on Cancer; 2013[cited 2019 Dec 10]. Available from: http://www.iarc.fr/en/publications/books/sp161/AirPollutionandCancer161.pdf.

32.

32. Hamra GB, Guha N, Cohen A, Laden F, Raaschou-Nielsen O, Samet JM, et al. Outdoor particulate matter exposure and lung cancer: a systematic review and meta-analysis. Environ Health Perspect 2014;122:906-11.

33.

33. Huang F, Pan B, Wu J, Chen E, Chen L. Relationship between exposure to PM2.5 and lung cancer incidence and mortality:a meta-analysis. Oncotarget 2017;8:43322-31.

34.

34. MacIntyre EA, Gehring U, Molter A, Fuertes E, Klumper C, Kramer U, et al. Air pollution and respiratory infections during early childhood: an analysis of 10 European birth cohorts within the ESCAPE Project. Environ Health Perspect 2014;122:107-13.

35.

35. Raaschou-Nielsen O, Andersen ZJ, Beelen R, Samoli E, Stafoggia M, Weinmayr G, et al. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol 2013;14:813-22.

36.

36. Kim HB, Shim JY, Park B, Lee YJ. Long-term exposure to air pollutants and cancer mortality: a meta-analysis of cohort studies. Int J Environ Res Public Health 2018;15:E2608.

37.

37. Suhaimi NF, Jalaludin J. Biomarker as a research tool in linking exposure to air particles and respiratory health. Biomed Res Int 2015;2015:962853.

38.

38. Cai Y, Schikowski T, Adam M, Buschka A, Carsin AE, Jacquemin B, et al. Cross-sectional associations between air pollution and chronic bronchitis: an ESCAPE meta-analysis across five cohorts. Thorax 2014;69:1005-14.

39.

39. Kyung SY, Jeong SH. Adverse health effects of particulate matter. J Korean Med Assoc 2017;60:391-8.

40.

40. Langrish JP, Li X, Wang S, Lee MM, Barnes GD, Miller MR, et al. Reducing personal exposure to particulate air pollution improves cardiovascular health in patients with coronary heart disease. Environ Health Perspect 2012;120:367-72.

41.

41. Langrish JP, Mills NL, Chan JK, Leseman DL, Aitken RJ, Fokkens PH, et al. Beneficial cardiovascular effects of reducing exposure to particulate air pollution with a simple facemask. Part Fibre Toxicol 2009;6:8.

42.

42. Roberge RJ, Coca A, Williams WJ, Powell JB, Palmiero AJ. Physiological impact of the N95 filtering facepiece respirator on healthcare workers. Respir Care 2010;55:569-77.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy